Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 02:14PM ET
2.08
Dollar change
+0.00
Percentage change
0.03
%
Index- P/E- EPS (ttm)-0.95 Insider Own41.78% Shs Outstand19.92M Perf Week2.50%
Market Cap54.95M Forward P/E- EPS next Y-1.01 Insider Trans0.19% Shs Float15.38M Perf Month-11.46%
Income-18.21M PEG- EPS next Q- Inst Own19.50% Short Float2.20% Perf Quarter-21.19%
Sales0.00M P/S- EPS this Y-24.00% Inst Trans19.79% Short Ratio2.52 Perf Half Y-50.10%
Book/sh1.06 P/B1.97 EPS next Y-8.60% ROA-76.56% Short Interest0.34M Perf Year2.50%
Cash/sh1.11 P/C1.87 EPS next 5Y- ROE-91.75% 52W Range1.55 - 7.75 Perf YTD-69.93%
Dividend Est.- P/FCF- EPS past 5Y-63.30% ROI-62.83% 52W High-73.15% Beta0.19
Dividend TTM- Quick Ratio5.82 Sales past 5Y0.00% Gross Margin- 52W Low34.24% ATR (14)0.21
Dividend Ex-Date- Current Ratio5.82 EPS Y/Y TTM-37.71% Oper. Margin0.00% RSI (14)46.05 Volatility7.35% 9.77%
Employees17 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-25.78% Payout- Rel Volume2.84 Prev Close2.08
Sales Surprise- EPS Surprise5.66% Sales Q/Q- Earnings- Avg Volume134.32K Price2.08
SMA20-3.25% SMA50-9.39% SMA200-41.38% Trades Volume283,137 Change0.03%
Jun-10-24 08:30AM
May-13-24 09:53AM
May-10-24 09:35AM
Apr-29-24 02:50PM
09:39AM
09:37AM Loading…
Apr-18-24 09:37AM
09:32AM
Apr-15-24 09:36AM
Apr-02-24 07:53AM
Mar-20-24 09:46AM
Mar-05-24 09:35AM
Feb-21-24 09:31AM
Feb-08-24 04:45PM
Feb-07-24 09:37AM
Feb-05-24 10:30PM
03:20PM Loading…
03:20PM
Jan-24-24 08:35AM
Jan-04-24 09:34AM
Dec-18-23 09:39AM
Dec-11-23 09:36AM
Nov-30-23 09:46AM
Nov-28-23 08:50AM
Nov-22-23 11:10AM
09:19AM
Nov-21-23 09:46AM
Nov-06-23 09:18AM
09:12AM
08:40AM
Oct-31-23 09:55AM
Oct-26-23 08:58AM
09:05AM Loading…
Oct-16-23 09:05AM
Oct-03-23 09:14AM
Oct-02-23 08:06AM
Sep-22-23 12:04PM
Sep-21-23 08:55AM
Sep-19-23 09:10AM
Sep-15-23 01:18PM
Sep-07-23 10:38AM
08:41AM
Sep-01-23 08:39AM
Aug-23-23 08:37AM
Aug-18-23 09:20AM
Aug-16-23 09:05AM
Jul-25-23 08:42AM
Jul-17-23 09:37AM
Jul-10-23 09:47AM
Jun-26-23 09:49AM
Jun-22-23 09:53AM
Jun-20-23 09:45AM
Jun-16-23 09:43AM
Jun-14-23 07:30AM
Jun-12-23 09:49AM
May-26-23 09:53AM
May-22-23 01:48PM
08:31AM
May-21-23 04:05PM
04:00PM
May-04-23 12:30PM
May-03-23 04:42PM
08:00AM
Apr-26-23 05:30PM
Apr-04-23 08:00AM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-10-23 07:45PM
Mar-06-23 08:00AM
Feb-27-23 08:45AM
Feb-15-23 08:30AM
Feb-09-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Jan-06-23 08:00AM
Dec-28-22 08:00AM
Dec-20-22 08:00AM
Dec-19-22 08:00AM
Dec-14-22 12:43PM
08:00AM
Dec-13-22 08:00AM
05:06AM
Dec-12-22 08:00AM
Nov-11-22 08:00AM
Oct-25-22 08:00AM
Oct-18-22 08:00AM
Sep-07-22 12:05PM
Aug-23-22 06:36AM
Aug-01-22 10:10AM
May-21-22 08:26AM
May-20-22 10:19AM
08:47AM
May-09-22 08:00AM
Apr-05-22 09:30AM
Mar-16-22 10:13AM
Mar-07-22 08:00AM
Feb-22-22 08:00AM
Feb-01-22 11:36AM
09:30AM
Jan-31-22 08:00AM
Jan-25-22 12:17PM
10:15AM
Jan-19-22 08:00AM
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rachman Ilya MCEO and ChairmanJun 07 '24Buy2.132,6005,5381,136,259Jun 10 09:00 AM
Morris Gabriel SCFOJun 07 '24Buy2.122,5005,298285,834Jun 10 09:00 AM
Morris Gabriel SCFOJun 04 '24Buy1.813,3005,973283,334Jun 05 09:00 AM
Rachman Ilya MCEO and ChairmanJun 04 '24Buy1.813,3005,9701,133,659Jun 05 09:00 AM
Morris Gabriel SCFOMay 14 '24Buy2.234,50010,04285,816May 14 09:29 PM
Rachman Ilya MCEO and ChairmanMay 14 '24Buy2.254,3009,660912,000May 14 09:28 PM
Hsu JasonDirectorDec 11 '23Buy4.6731,000144,894813,000Dec 12 06:25 PM
Hsu JasonDirectorDec 08 '23Buy4.8825,000122,025782,000Dec 12 06:25 PM
Hsu JasonDirectorSep 15 '23Buy2.497,00017,396757,000Sep 18 07:03 PM
Hsu JasonDirectorSep 14 '23Buy2.5810,00025,772750,000Sep 18 07:03 PM
Ng CareyDirectorSep 14 '23Buy2.5810,00025,76010,000Sep 15 06:27 PM
Hsu JasonDirectorSep 12 '23Buy2.8330,00084,864740,000Sep 18 07:03 PM
Adams Helen C.DirectorSep 12 '23Buy2.9613,00038,49213,000Sep 14 05:20 PM
Hsu JasonDirectorSep 11 '23Buy2.8925,00072,280710,000Sep 18 07:03 PM
Hsu JasonDirectorSep 08 '23Buy2.5310,00025,317685,000Sep 12 04:58 PM
BUCHAN MELISSA JANEDirectorSep 07 '23Buy2.4620,00049,22620,000Sep 11 05:18 PM
Marquet MagdaDirectorSep 06 '23Buy2.479,00022,21320,000Sep 08 05:46 PM
Marquet MagdaDirectorSep 05 '23Buy2.4710,00024,72211,000Sep 06 04:33 PM
Marquet MagdaDirectorAug 31 '23Buy2.011,0002,0101,000Sep 05 06:43 PM